Cargando…
Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells
Long non-coding RNAs (lncRNAs) can play significant regulatory roles in cells that affect the development and acquired drug resistance of lung cancer. Herein, we report that lncRNA linc00665 is significantly upregulated in non-small cell lung cancer (NSCLC) tissues compared with adjacent normal tiss...
Autores principales: | Yang, Daolu, Feng, Wenyan, Zhuang, Yu, Liu, Junxia, Feng, Zhenqing, Xu, Tianwei, Wang, Wei, Zhu, Yefei, Wang, Zhaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887328/ https://www.ncbi.nlm.nih.gov/pubmed/33664990 http://dx.doi.org/10.1016/j.omtn.2021.01.013 |
Ejemplares similares
-
LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
por: Liu, Xinyin, et al.
Publicado: (2019) -
The Emerging Roles of LINC00665 in Human Cancers
por: Zhu, Jing, et al.
Publicado: (2022) -
Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
por: Dai, Huijuan, et al.
Publicado: (2021) -
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
por: Zhong, Chenming, et al.
Publicado: (2022) -
The Biological and Molecular Function of LINC00665 in Human Cancers
por: Zhang, Cheng, et al.
Publicado: (2022)